Five things to know:
1. U.S. sales grew 24 percent compared to the same period in 2021 with $51.1 million.
2. U.S. spinal implants and enabling technologies revenue of $27.4 million represents a 30 percent year-over-year increase.
3. U.S. orthobiologic sales of $23.8 million was an 18 percent increase year-over-year.
4. International sales leaped 207 percent compared to the third quarter of 2021 with $16 million.
5. SeaSpine saw a net loss of $15.5 million in the third quarter.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
